Bu S, Liu M, Yang L, Lee P, Miller H, Park C
Front Immunol. 2025; 16:1499014.
PMID: 40061938
PMC: 11885273.
DOI: 10.3389/fimmu.2025.1499014.
Zawidzka E, Biavati L, Thomas A, Zanettini C, Marchionni L, Leone R
J Immunother Cancer. 2025; 13(2).
PMID: 40010772
PMC: 11865787.
DOI: 10.1136/jitc-2024-009367.
Kaur G, Banaag S, Hong L, Mylavarapu C, Kim Y, Garrett J
Clin Case Rep. 2025; 13(2):e70102.
PMID: 39886060
PMC: 11780247.
DOI: 10.1002/ccr3.70102.
Fogerty A
Hematology Am Soc Hematol Educ Program. 2024; 2024(1):685-691.
PMID: 39643994
PMC: 11665594.
DOI: 10.1182/hematology.2024000595.
Gu S, Chen M, Xu W, Zhang H, Zhou H
Ann Hematol. 2024; .
PMID: 39614925
DOI: 10.1007/s00277-024-06105-z.
Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment.
Zheng S, Perdomo J
Curr Issues Mol Biol. 2024; 46(11):11942-11956.
PMID: 39590303
PMC: 11592706.
DOI: 10.3390/cimb46110709.
rs1800890 Polymorphism of IL-10 and Susceptibility to Idiopathic Thrombocytopenic Purpura.
Zeylabi F, Jalali M, Kaydani G, Jaseb K, Saki N
J Pediatr Genet. 2024; 13(4):263-271.
PMID: 39502848
PMC: 11534459.
DOI: 10.1055/s-0043-1775558.
The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP).
Sun L, Zhang Y, Chen P, Jiang N, Feng Q, Xu S
Ann Hematol. 2024; 103(12):5157-5168.
PMID: 39271523
DOI: 10.1007/s00277-024-05999-z.
ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats.
LeVine D, Goggs R, Kohn B, Mackin A, Kidd L, Garden O
J Vet Intern Med. 2024; 38(4):1982-2007.
PMID: 38779941
PMC: 11256181.
DOI: 10.1111/jvim.17079.
ACVIM consensus statement on the diagnosis of immune thrombocytopenia in dogs and cats.
LeVine D, Kidd L, Garden O, Brooks M, Goggs R, Kohn B
J Vet Intern Med. 2024; 38(4):1958-1981.
PMID: 38752421
PMC: 11256148.
DOI: 10.1111/jvim.16996.
Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective.
Martinez-Carballeira D, Bernardo A, Caro A, Soto I, Gutierrez L
Hematol Rep. 2024; 16(2):204-219.
PMID: 38651450
PMC: 11036214.
DOI: 10.3390/hematolrep16020021.
Immune attack on megakaryocytes in immune thrombocytopenia.
Petito E, Gresele P
Res Pract Thromb Haemost. 2024; 8(1):102345.
PMID: 38525349
PMC: 10960061.
DOI: 10.1016/j.rpth.2024.102345.
Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options.
Mititelu A, Onisai M, Rosca A, Vladareanu A
Int J Mol Sci. 2024; 25(4).
PMID: 38396839
PMC: 10889445.
DOI: 10.3390/ijms25042163.
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.
Kuter D, Mayer J, Efraim M, Bogdanov L, Baker R, Kaplan Z
Blood Adv. 2024; 8(7):1715-1724.
PMID: 38386978
PMC: 10997915.
DOI: 10.1182/bloodadvances.2023012044.
Checkpoint inhibitors.
Kroll M
Hematology Am Soc Hematol Educ Program. 2023; 2023(1):209-215.
PMID: 38066867
PMC: 10727098.
DOI: 10.1182/hematology.2023000523.
Pathogenesis of refractory ITP: Overview.
Cines D
Br J Haematol. 2023; 203(1):10-16.
PMID: 37735546
PMC: 10539016.
DOI: 10.1111/bjh.19083.
Rituximab resistance in ITP and beyond.
Xiao Z, Murakhovskaya I
Front Immunol. 2023; 14:1215216.
PMID: 37575230
PMC: 10422042.
DOI: 10.3389/fimmu.2023.1215216.
The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia.
Xiang Y, Liu L, Hou Y, Du S, Xu S, Zhou H
Ann Hematol. 2023; 102(9):2317-2327.
PMID: 37421506
DOI: 10.1007/s00277-023-05348-6.
Life-Threatening Intracerebral Hemorrhage in Adult with ITP: Challenging Entity.
Diyora B, Purandare A, Devani K, Kale P, Shah V, Patankar R
Asian J Neurosurg. 2023; 18(2):391-395.
PMID: 37397035
PMC: 10313438.
DOI: 10.1055/s-0043-1769891.
Refractory Immune Thrombocytopenic Purpura with Abdominal Splenosis: A Complex Case.
Mort J, Tran D, Dougherty S, Zielinski R, Williams M, Davidson K
Case Rep Hematol. 2023; 2023:9714457.
PMID: 37388486
PMC: 10307128.
DOI: 10.1155/2023/9714457.